Trials / Completed
CompletedNCT00139295
Comparison of Hylastan to Methylprednisolone Acetate in Patients With Symptomatic Osteoarthritis of the Knee
Comparison of the Efficacy and Safety of Hylastan to Methylprednisolone Acetate in Patients With Symptomatic Osteoarthritis of the Knee
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Genzyme, a Sanofi Company · Industry
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
This is a clinical study to investigate the safety and efficacy of hylastan in treating patients with symptomatic osteoarthritis (OA) of the knee.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Hylastan |
Timeline
- Start date
- 2004-10-01
- Completion
- 2007-09-01
- First posted
- 2005-08-31
- Last updated
- 2014-02-05
Locations
24 sites across 5 countries: United States, Canada, France, Germany, United Kingdom
Source: ClinicalTrials.gov record NCT00139295. Inclusion in this directory is not an endorsement.